GENETIC-MARKER ASSOCIATIONS WITH PROLIFERATIVE RETINOPATHY IN PERSONS DIAGNOSED WITH DIABETES BEFORE 30-YR OF AGE

被引:55
作者
CRUICKSHANKS, KJ
VADHEIM, CM
MOSS, SE
ROTH, MP
RILEY, WJ
MACLAREN, NK
LANGFIELD, D
SPARKES, RS
KLEIN, R
ROTTER, JI
机构
[1] CEDARS SINAI SCH MED, LOS ANGELES, CA USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV MED GENET, LOS ANGELES, CA 90024 USA
[3] UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, DIV MED GENET, LOS ANGELES, CA 90024 USA
[4] UNIV CALIF LOS ANGELES, CTR HLTH SCI, DIV MED GENET, LOS ANGELES, CA 90024 USA
[5] INSERM, U100, TOULOUSE, FRANCE
[6] UNIV FLORIDA, DEPT PATHOL, GAINESVILLE, FL 32611 USA
[7] UNIV FLORIDA, MED LAB, GAINESVILLE, FL 32611 USA
关键词
D O I
10.2337/diabetes.41.7.879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been suggested that HLA-DR4 is a marker of genetic predisposition to proliferative retinopathy. To investigate this relationship and potential associations between other polymorphic genes and proliferative retinopathy, a sample (n = 428) of participants in the population-based Wisconsin Epidemiologic Study of Diabetic Retinopathy was selected for typing for HLA-A, -B, -C, and -DR and a panel of other polymorphic genes. The presence of proliferative retinopathy was determined from grading of stereoscopic color fundus photographs taken at 2 examinations, 4 yr apart. In logistic regression models with repeated measures, persons with HLA-DR4 who were negative for DR3 were five times more likely to have proliferative retinopathy than those negative for both antigens after adjusting for other potential risk factors (Odds ratio = 5.43, 95% Confidence Interval (CI) = 1.04, 28.30). H LA-C2, A K-2, and MNSs-S also were associated positively with proliferative retinopathy, and HLA-DR8 was associated inversely with this complication of diabetes in each case before adjusting for the number of comparisons. These data suggest that the genetically determined immunopathic mechanisms leading to diabetes, and in linkage disequilibrium with DR4, may independently contribute to the development of proliferative retinopathy.
引用
收藏
页码:879 / 885
页数:7
相关论文
共 44 条
[1]  
[Anonymous], 1985, EARLY TREATMENT DIAB
[2]  
[Anonymous], 1976, HDB ENZYME ELECTROPH
[3]  
[Anonymous], 1981, INVEST OPHTHALMOL VI, V21, P210
[4]   INFLUENCE OF HLA-DR PHENOTYPE AND MYOPIA ON THE RISK OF NONPROLIFERATIVE AND PROLIFERATIVE DIABETIC-RETINOPATHY [J].
BAKER, RS ;
RAND, LI ;
KROLEWSKI, AS ;
MAKI, T ;
WARRAM, JH ;
AIELLO, LM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 102 (06) :693-700
[5]   HISTOCOMPATIBILITY ANTIGEN FREQUENCIES IN DIABETIC-RETINOPATHY [J].
BARBOSA, J ;
RAMSAY, RC ;
KNOBLOCH, WH ;
CANTRILL, HL ;
NOREEN, H ;
KING, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1980, 90 (02) :148-153
[6]   HISTOCOMPATIBILITY ANTIGENS AND DIABETIC-RETINOPATHY [J].
BECKER, B ;
SHIN, DH ;
BURGESS, D ;
KILO, C ;
MILLER, WV .
DIABETES, 1977, 26 (10) :997-999
[7]  
BERTRAMS J, 1979, 10TH P C INT DIAB FE, P213
[8]   GENETIC AND IMMUNOLOGICAL FACTORS IN MICRO-VASCULAR DISEASE IN TYPE-I INSULIN-DEPENDENT DIABETES [J].
BODANSKY, HJ ;
WOLF, E ;
CUDWORTH, AG ;
DEAN, BM ;
NINEHAM, LJ ;
BOTTAZZO, GF ;
MATTHEWS, JA ;
KURTZ, AB ;
KOHNER, EM .
DIABETES, 1982, 31 (01) :70-74
[9]  
BODANSKY HJ, 1981, DIABETOLOGIA, V20, P585
[10]   ARE HLA TYPES OR BF ALLELES MARKERS FOR DIABETIC-RETINOPATHY [J].
COVE, DH ;
WALKER, JM ;
WELLS, L ;
MACKINTOSH, P .
DIABETOLOGIA, 1980, 19 (04) :402-403